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Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor
and accounts for a significant proportion of all primary brain tumors. Median survival
after treatment is around 15 months. Remodeling of N-glycans by the N-
acetylglucosamine glycosyltransferase (MGAT5) regulates tumoral development. Here,
perturbation of MGAT5 enzymatic activity by the small-molecule inhibitor 3-
hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl2-oxo-2λ5-[1,2]oxaphosphinane
(PST3.1a) restrains GBM growth. In cell-based assays, it is demonstrated that PST3.1a
alters the β1,6-GlcNAc N-glycans of GBM-initiating cells (GIC) by inhibiting MGAT5
enzymatic activity, resulting in the inhibition of TGFβR and FAK signaling associated
with doublecortin (DCX) upregulation and increase oligodendrocyte lineage
transcription factor 2 (OLIG2) expression. PST3.1a thus affects microtubule and
microfilament integrity of GBM stem cells, leading to the inhibition of GIC proliferation,
migration, invasiveness, and clonogenic capacities. Orthotopic graft models of GIC
revealed that PST3.1a treatment leads to a drastic reduction of invasive and
proliferative capacity and to an increase in overall survival relative to standard
temozolomide therapy. Finally, bioinformatics analyses exposed that PST3.1a cytotoxic
activity is positively correlated with the expression of genes of the epithelial-
mesenchymal transition (EMT), while the expression of mitochondrial genes correlated
negatively with cell sensitivity to the compound. These data demonstrate the relevance
of targeting MGAT5, with a novel anti-invasive chemotherapy, to limit glioblastoma
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